Table 1.

Study inclusion and exclusion criteria

	Inclusion criteria	Exclusion criteria
Study design	Regardless of methodology, qualifying studies that answered the question ‘what factors influence the reporting of ADRs by the public?’ were included	Letters, editorials and narrative reviews were excluded
Participants	All studies addressing patients' perceptions of ADR reporting were included	Studies addressing patient and HCP roles in pharmacovigilance; perception of HCPs on ADR reporting; studies comparing frequencies of reported ADRs by patients vs. HCPs; frequencies of ADRs reported by patients; and studies addressing the role of regulators on pharmacovigilance
Language	Studies reported in all languages, if we were able to translate them	Studies unable to translate

ADR, adverse drug reaction; HCP, healthcare professional